National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1214117

Government Disclaimer on use of this data

History of Changes from the VAERS Wayback Machine

First Appeared on 4/23/2021

VAERS ID: 1214117
VAERS Form:2
Age:44.0
Sex:Male
Location:Ohio
Vaccinated:2021-04-12
Onset:2021-04-14
Submitted:0000-00-00
Entered:2021-04-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 205A21A / UNK RA / SYR

Administered by: Pharmacy      Purchased by: ??
Symptoms: Guillain-Barre syndrome, Pain in extremity, Laboratory test

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? Yes
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? Yes
Hospitalized? No
Previous Vaccinations: Yellow Fever Vaccine/2014
Other Medications: Vitamin D, K, Vitamin B complex Multivitamin Fish Oil
Current Illness: None
Preexisting Conditions: None
Allergies: Yellow Fever Vaccine
Diagnostic Lab Data: He received IV Toradol to help out with his extremity pain. Labs were checked to rule out electrolyte disturbance, thrombocytopenia. The patient''s neurologic examination does not demonstrate classic signs of Guillain-Barre, there is no evidence of muscle weakness or paralysis and his deep tendon reflexes are normal. Acute pain has been described in acute Guillain-Barre, and so I gave the patient return precautions regarding progressive symptoms. At this point, there are not enough objective criteria to diagnose him with GBS, symptoms do not suggest the need for hospitalization for observation. Even so, it is clear the severe extremity pain is a result of the vaccine.
CDC 'Split Type':

Write-up: Patient developed mild case of Guillain Barre Syndrome 34 hours after injection of the Johnson and Johnson vaccine. Patient has severe extremity pains. The patient has a personal history of being diagnosed with Guillain-Barre after a yellow fever vaccination.


Changed on 5/7/2021

VAERS ID: 1214117 Before After
VAERS Form:2
Age:44.0
Sex:Male
Location:Ohio
Vaccinated:2021-04-12
Onset:2021-04-14
Submitted:0000-00-00
Entered:2021-04-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 205A21A / UNK RA / SYR

Administered by: Pharmacy      Purchased by: ??
Symptoms: Guillain-Barre syndrome, Pain in extremity, Laboratory test

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? Yes
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? Yes
Hospitalized? No
Previous Vaccinations: Yellow Fever Vaccine/2014
Other Medications: Vitamin D, K, Vitamin B complex Multivitamin Fish Oil
Current Illness: None
Preexisting Conditions: None
Allergies: Yellow Fever Vaccine Vaccine
Diagnostic Lab Data: He received IV Toradol to help out with his extremity pain. Labs were checked to rule out electrolyte disturbance, thrombocytopenia. The patient''s neurologic examination does not demonstrate classic signs of Guillain-Barre, there is no evidence of muscle weakness or paralysis and his deep tendon reflexes are normal. Acute pain has been described in acute Guillain-Barre, and so I gave the patient return precautions regarding progressive symptoms. At this point, there are not enough objective criteria to diagnose him with GBS, symptoms do not suggest the need for hospitalization for observation. Even so, it is clear the severe extremity pain is a result of the vaccine.
CDC 'Split Type':

Write-up: Patient developed mild case of Guillain Barre Syndrome 34 hours after injection of the Johnson and Johnson vaccine. Patient has severe extremity pains. The patient has a personal history of being diagnosed with Guillain-Barre after a yellow fever vaccination.


Changed on 5/14/2021

VAERS ID: 1214117 Before After
VAERS Form:2
Age:44.0
Sex:Male
Location:Ohio
Vaccinated:2021-04-12
Onset:2021-04-14
Submitted:0000-00-00
Entered:2021-04-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 205A21A / UNK RA / SYR

Administered by: Pharmacy      Purchased by: ??
Symptoms: Guillain-Barre syndrome, Pain in extremity, Laboratory test

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? Yes
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? Yes
Hospitalized? No
Previous Vaccinations: Yellow Fever Vaccine/2014
Other Medications: Vitamin D, K, Vitamin B complex Multivitamin Fish Oil
Current Illness: None
Preexisting Conditions: None
Allergies: Yellow Fever Vaccine Vaccine
Diagnostic Lab Data: He received IV Toradol to help out with his extremity pain. Labs were checked to rule out electrolyte disturbance, thrombocytopenia. The patient''s neurologic examination does not demonstrate classic signs of Guillain-Barre, there is no evidence of muscle weakness or paralysis and his deep tendon reflexes are normal. Acute pain has been described in acute Guillain-Barre, and so I gave the patient return precautions regarding progressive symptoms. At this point, there are not enough objective criteria to diagnose him with GBS, symptoms do not suggest the need for hospitalization for observation. Even so, it is clear the severe extremity pain is a result of the vaccine.
CDC 'Split Type':

Write-up: Patient developed mild case of Guillain Barre Syndrome 34 hours after injection of the Johnson and Johnson vaccine. Patient has severe extremity pains. The patient has a personal history of being diagnosed with Guillain-Barre after a yellow fever vaccination.

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1214117&WAYBACKHISTORY=ON


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166